Eye health and vision have widespread and profound implications for many aspects of life,
health, sustainable development, and the economy. Yet nowadays, many people, families …

Retinoblastoma management remains complex, requiring individualized treatment based on
International Classification of Retinoblastoma (ICRB) staging, germline mutation status …

This guideline aims to improve the quality of essential, routine postnatal care for women and
newborns with the ultimate goal of improving maternal and newborn health and well-being …

The management of retinoblastoma, the most common intraocular malignancy in children,
has changed drastically over the last decade. Landmark developments in local drug …

Background Retinoblastoma is the most common intraocular cancer worldwide. There is
some evidence to suggest that major differences exist in treatment outcomes for children …

Background Despite advancements in globe-preserving treatments, improvements in
retinoblastoma outcomes are inconsistent across income levels and geographical locations …

Purpose To compare metastasis-related mortality, local treatment failure and globe salvage
after retinoblastoma (RB) in countries with different national income levels. Design …

Retinoblastoma (Rb), the most frequent malignant intraocular tumor in childhood, is caused
by mutations in the retinoblastoma gene (RB1) situated on chromosome 13q14. 2. The …

Retinoblastoma is the most common intraocular malignancy. Its incidence has been
reported to be 1 case in from 15 000 to 18 000 live births, or approximately 12, 6, or 4 cases …

Retinoblastoma is the most common paediatric neoplasm of the retina, and one of the
earliest model of cancer genetics since the identification of the master tumour suppressor …